EAGLE ASSET MANAGEMENT INC - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
EAGLE ASSET MANAGEMENT INC ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,963,198
-21.6%
1,042,395
-1.5%
0.04%
-16.3%
Q2 2023$8,881,200
-51.5%
1,058,546
-42.6%
0.05%
-54.2%
Q1 2023$18,311,000
+48.5%
1,844,010
+4.1%
0.11%
+40.8%
Q4 2022$12,330,000
+58.4%
1,771,689
+21.5%
0.08%
+49.0%
Q3 2022$7,785,000
+29.6%
1,458,008
-3.2%
0.05%
+34.2%
Q2 2022$6,008,000
-8.3%
1,505,938
+2.2%
0.04%
+11.8%
Q1 2022$6,549,000
+15.8%
1,473,459
+5.8%
0.03%
+36.0%
Q4 2021$5,655,000
-52.2%
1,392,936
+3.5%
0.02%
-52.8%
Q3 2021$11,821,000
-3.9%
1,346,468
+24.0%
0.05%0.0%
Q2 2021$12,298,0001,085,5180.05%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Prosight Management, LP 1,155,300$4,621,0002.77%
Knoll Capital Management, LLC 759,405$3,038,0001.67%
ACUTA CAPITAL PARTNERS, LLC 500,000$2,000,0000.84%
Perceptive Advisors 19,807,758$79,232,0000.61%
Mesirow Financial Investment Management, Inc. 48,711$195,0000.56%
Ghost Tree Capital, LLC 300,000$1,200,0000.43%
Stonepine Capital Management, LLC 200,000$800,0000.37%
APOGEM CAPITAL LLC 86,730$347,0000.23%
JOHNSON & JOHNSON 394,834$1,579,0000.18%
Affinity Asset Advisors, LLC 100,759$403,0000.15%
View complete list of ALDEYRA THERAPEUTICS INC shareholders